Cargando…
Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers
Head and neck squamous cell carcinomas (HNSCC) have a high mortality rate, although several potential therapeutic targets have already been identified. Gonadotropin-releasing hormone receptor (GnRH-R) expression is less studied in head and neck cancers, hence, we investigated the therapeutic relevan...
Autores principales: | Pethő, Lilla, Murányi, József, Pénzes, Kinga, Gurbi, Bianka, Brauswetter, Diána, Halmos, Gábor, Csík, Gabriella, Mező, Gábor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829278/ https://www.ncbi.nlm.nih.gov/pubmed/31614426 http://dx.doi.org/10.3390/ijms20205027 |
Ejemplares similares
-
Novel Crizotinib–GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems
por: Murányi, József, et al.
Publicado: (2019) -
Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates
por: Schuster, Sabine, et al.
Publicado: (2022) -
Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification
por: Schuster, Sabine, et al.
Publicado: (2018) -
Protein Expression Profile of HT-29 Human Colon Cancer Cells after Treatment with a Cytotoxic Daunorubicin-GnRH-III Derivative Bioconjugate
por: Schreier, Verena Natalie, et al.
Publicado: (2014) -
Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
por: Schuster, Sabine, et al.
Publicado: (2018)